Cardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report)’s stock price dropped 3.1% during mid-day trading on Tuesday . The stock traded as low as $1.55 and last traded at $1.57. Approximately 335,697 shares traded hands during mid-day trading, an increase of 400% from the average daily volume of 67,097 shares. The stock had previously closed at $1.62.
Cardiol Therapeutics Stock Down 2.5 %
The firm has a 50 day moving average of $1.85 and a 200-day moving average of $2.05.
About Cardiol Therapeutics
Cardiol Therapeutics Inc is a clinical-stage biotechnology company that focuses on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its product, CardiolRx, is a pharmaceutically produced extra strength oral cannabidiol formulation that is entering a Phase II/III outcomes study in hospitalized patients testing positive for the COVID-19 virus.
Recommended Stories
- Five stocks we like better than Cardiol Therapeutics
- The Role Economic Reports Play in a Successful Investment Strategy
- Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025
- What Are Growth Stocks and Investing in Them
- Netflix Is On Track To Hit $1,000 By Christmas
- What is a Bond Market Holiday? How to Invest and Trade
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
